Atomico leads $20M Series A funding round in Gaia a startup that aims to de-risk IVF treatments
Gaia is a startup that aims to "de-risk" the entire IVF reproductive treatment procedure. The company has recently completed a $20 million Series A investment round. Gaia aims to reduce the risks associated with IVF fertility treatment by offering goods such as tailored insurance and payment options. Atomico, a London-based venture capital firm, led the startup's $20 million Series A fundraising round. Kindred Capital, Seedcamp, and Clocktower Technology Ventures, all based in the United States, have previously invested. Gaia has already raised a total of $23 million. Sasha Astafyeva, an Atomico partner, will join the Gaia board of directors. In addition to insurance and payment arrangements, Gaia claims to have predictive technology that forecasts the number of rounds a couple will likely require, as well as clinics that can provide the appropriate treatment, based on clinical data sets. Gaia CEO and founder Nader AlSalim stated, "The fertility care m...